ASRT Valuation

Assertio Holdings Inc

Add to Watchlist

Advanced Chart

0.835

+0.024(2.959%)1D

Overview
Forecast
Valuation
Earnings

ASRT Relative Valuation

ASRT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ASRT is overvalued; if below, it's undervalued.

Historical Valuation

Assertio Holdings Inc (ASRT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.67 is considered Undervalued compared with the five-year average of 7.25. The fair price of Assertio Holdings Inc (ASRT) is between 25.20 to 26.06 according to relative valuation methord. Compared to the current price of 0.83 USD , Assertio Holdings Inc is Undervalued By 96.71%.

Relative Value

Fair Zone

25.20-26.06

Current Price：0.83

96.71%

Undervalued

-3.41

Trailing

Forward

1.19

EV/EBITDA

Assertio Holdings Inc. (ASRT) has a current EV/EBITDA of 1.19. The 5-year average EV/EBITDA is 2.66. The thresholds are as follows: Strongly Undervalued below -0.19, Undervalued between -0.19 and 1.23, Fairly Valued between 4.08 and 1.23, Overvalued between 4.08 and 5.51, and Strongly Overvalued above 5.51. The current Forward EV/EBITDA of 1.19 falls within the Undervalued range.

-0.77

EV/EBIT

Assertio Holdings Inc. (ASRT) has a current EV/EBIT of -0.77. The 5-year average EV/EBIT is 4.65. The thresholds are as follows: Strongly Undervalued below -25.99, Undervalued between -25.99 and -10.67, Fairly Valued between 19.97 and -10.67, Overvalued between 19.97 and 35.29, and Strongly Overvalued above 35.29. The current Forward EV/EBIT of -0.77 falls within the Historic Trend Line -Fairly Valued range.

0.70

Assertio Holdings Inc. (ASRT) has a current PS of 0.70. The 5-year average PS is 0.94. The thresholds are as follows: Strongly Undervalued below 0.08, Undervalued between 0.08 and 0.51, Fairly Valued between 1.37 and 0.51, Overvalued between 1.37 and 1.79, and Strongly Overvalued above 1.79. The current Forward PS of 0.70 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Assertio Holdings Inc. (ASRT) has a current P/OCF of 0.00. The 5-year average P/OCF is 3.49. The thresholds are as follows: Strongly Undervalued below -3.46, Undervalued between -3.46 and 0.02, Fairly Valued between 6.97 and 0.02, Overvalued between 6.97 and 10.44, and Strongly Overvalued above 10.44. The current Forward P/OCF of 0.00 falls within the Undervalued range.

0.00

P/FCF

Assertio Holdings Inc. (ASRT) has a current P/FCF of 0.00. The 5-year average P/FCF is 3.97. The thresholds are as follows: Strongly Undervalued below -4.26, Undervalued between -4.26 and -0.14, Fairly Valued between 8.09 and -0.14, Overvalued between 8.09 and 12.20, and Strongly Overvalued above 12.20. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Assertio Holdings Inc (ASRT) has a current Price-to-Book (P/B) ratio of 0.84. Compared to its 3-year average P/B ratio of 0.85 , the current P/B ratio is approximately -1.16% higher. Relative to its 5-year average P/B ratio of 0.89, the current P/B ratio is about -6.33% higher. Assertio Holdings Inc (ASRT) has a Forward Free Cash Flow (FCF) yield of approximately 24.50%. Compared to its 3-year average FCF yield of 32.49%, the current FCF yield is approximately -24.60% lower. Relative to its 5-year average FCF yield of 8.16% , the current FCF yield is about 200.28% lower.

0.86

P/B

Median3y

0.85

Median5y

0.89

23.26

FCF Yield

Median3y

32.49

Median5y

8.16

Competitors Valuation Multiple

The average P/S ratio for ASRT's competitors is 87.27, providing a benchmark for relative valuation. Assertio Holdings Inc Corp (ASRT) exhibits a P/S ratio of 0.70, which is -99.19% above the industry average. Given its robust revenue growth of -6.12%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ASRT.O

Assertio Holdings Inc

Applied Therapeutics Inc

Ovid Therapeutics Inc

Performance Decomposition

Market capitalization of ASRT decreased by 29.23% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -11.80 to -55.96.

The secondary factor is the Revenue Growth, contributed -6.12%to the performance.

Overall, the performance of ASRT in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-6.12%

31.13M → 29.22M

Revenue Growth

374.24%

-11.80 → -55.96

Margin Expansion

-397.35%

0.62 → -1.84

P/E Change

-29.23%